Summit Therapeutics Reports Financial Results for the Third Quarter Ended 31 October 2015 and Operational Progress

Go back to Summit Therapeutics Reports Financial Results for the Third Quarter Ended 31 October 2015 and Operational Progress

Summit Therapeutics (SMMT) Reports Q3 Loss of GBP0.08/Share

December 17, 2015 7:10 AM EST

Summit Therapeutics (NASDAQ: SMMT) reported Q3 EPS of (GBP0.08), versus (GBP0.06) reported last year.

For earnings history and earnings-related data on Summit Therapeutics (SMMT) click here.

... More